slides · global inventory
Monroes Sequence
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 33,236
Current window 19,801-19,830
Pages 1,108
Rows per page 30
Arc
19,801-19,830 of 33,236
01
AstraZeneca | Investor Event Presentation Deck | 52 slidesAstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
02
AstraZeneca | Investor Event Presentation Deck | 52 slidesAstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
03
AstraZeneca | Investor Event Presentation Deck | 52 slidesAstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
04
The slide is divided into two sections: 'Speakers and panelists' and 'Therapeutic Area Leadership'.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
05
AstraZeneca | Investor Event Presentation Deck | 52 slidesAstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a combination of stacked bar charts for revenue composition and a horizontal bar chart for growth metrics.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
07
Includes a timeline of 5 years of Plenary Presentations.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
08
AstraZeneca | Investor Event Presentation Deck | 52 slidesAstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
09
The diagram illustrates a hub-and-spoke model where the central hub is 'Diverse portfolio for combinations' and the spokes are the various therapeutic areas.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
The slide uses a timeline framework to highlight key clinical trial milestones.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
11
The slide features a headshot of the speaker and a medical illustration of cells.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
The slide uses a standard clinical trial process flow diagram.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
Kaplan-Meier survival curves showing primary (2020) and updated (2023) analysis results.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
14
Includes Kaplan-Meier survival curve and 'number at risk' table.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
15
Clinical trial data visualization (Kaplan-Meier plot).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
16
The slide displays a Kaplan-Meier survival analysis with a corresponding 'number at risk' table and key statistical metrics (HR, CI, p-value).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
17
Standard forest plot used in clinical trial reporting.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
18
Includes two distinct data cut-off dates for different parts of the safety summary.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
19
Slide 20 of a presentation; includes technical definitions and study references in the footer.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
05
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
06
Operating Expenses chart is a stacked bar chart showing OpEx vs SBC + Non-recurring costs.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
The slide compares previous vs updated guidance for FY 2023 and break-even targets.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
03
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Attention1 hit
05
Data source: China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
12
Data shows a decline in revenue but an improvement in gross margin.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
13
The slide explains the drivers behind the reduction in G&A and S&M expenses, specifically citing share-based compensation reversals and store closures.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
14
Includes a footnote explaining the non-GAAP definition and methodology.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
15
The chart displays quarterly operating cashflow as bars and the total cash balance as oval-enclosed numbers above the bars.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit